Select Bibliography

Filter by any of these (after searching):

Iyer, Gopa

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for those Patients whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations (Alliance A031701)

Iyer, Gopa , Ballman, Karla V. , Atherton, Pamela , Murray, Katie ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - Alliance-A031701

Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance)

Iyer, Gopa , Halabi, Susan , Luo, Bin , Choi, Woonyoung ... - ASCO - J Clin Oncol - 2022

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90601

Association between molecular subtype membership or hypoxia-associated gene expression signatures and clinical outcomes in the CALGB 90601 (Alliance) Phase 3 clinical trial of Gemcitabine and Cisplatin (GC) plus bevacizumab (B) or placebo (P)

McConkey, David J , Choi, Woonyoung , Halabi, Susan , Luo, Bin ... - ASCO - J Clin Oncol - 2022

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90601